THERAPEUTIC TARGETING OF BREAST CANCER AND HOST IMMUNE RESPONSES AT INFLECTION POINTS IN THE DISEASE TRAJECTORY
$6,716,989FY2021Defense Health AgencyDOD
Brigham & Womens Hospital Inc
Investigators
View source on USAspending →THERAPEUTIC TARGETING OF BREAST CANCER AND HOST IMMUNE RESPONSES AT INFLECTION POINTS IN THE DISEASE TRAJECTORY · GrantIndex